BackVBI Vaccines Overview

VBI Vaccines Selling, General & Admin

VBI Vaccines selling, general & admin — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$7.67M
42.25% YoY

As of Mar 31, 2024

Annual SG&A Expenses (TTM)

$36.06M
38.34% YoY

Trailing 12 months ending Mar 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

VBI Vaccines (VBIV) FAQ

Stockcircle tracks selling, general & admin for VBI Vaccines (VBIV), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for VBI Vaccines's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main VBIV overview so you can move from this figure to the surrounding analysis quickly.